GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (TSXV:CANB) » Definitions » Net Margin %

CanadaBis Capital (TSXV:CANB) Net Margin % : 2.55% (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is CanadaBis Capital Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. CanadaBis Capital's Net Income for the three months ended in Jan. 2024 was C$0.11 Mil. CanadaBis Capital's Revenue for the three months ended in Jan. 2024 was C$4.31 Mil. Therefore, CanadaBis Capital's net margin for the quarter that ended in Jan. 2024 was 2.55%.

The historical rank and industry rank for CanadaBis Capital's Net Margin % or its related term are showing as below:

TSXV:CANB' s Net Margin % Range Over the Past 10 Years
Min: -121.68   Med: -16.89   Max: 20
Current: 15.62


TSXV:CANB's Net Margin % is ranked better than
81.84% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.17 vs TSXV:CANB: 15.62

CanadaBis Capital Net Margin % Historical Data

The historical data trend for CanadaBis Capital's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital Net Margin % Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23
Net Margin %
Get a 7-Day Free Trial - -121.68 -38.99 5.21 20.00

CanadaBis Capital Quarterly Data
Mar19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.82 19.82 26.01 12.31 2.55

Competitive Comparison of CanadaBis Capital's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Net Margin % distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's Net Margin % falls into.



CanadaBis Capital Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

CanadaBis Capital's Net Margin for the fiscal year that ended in Jul. 2023 is calculated as

Net Margin=Net Income (A: Jul. 2023 )/Revenue (A: Jul. 2023 )
=4.444/22.222
=20.00 %

CanadaBis Capital's Net Margin for the quarter that ended in Jan. 2024 is calculated as

Net Margin=Net Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=0.11/4.309
=2.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital  (TSXV:CANB) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


CanadaBis Capital Net Margin % Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital (TSXV:CANB) Business Description

Traded in Other Exchanges
Address
PO Box 850, Rocky Mountain House, AB, CAN, T4T 1A6
CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.
Executives
Garfield Richards Senior Officer

CanadaBis Capital (TSXV:CANB) Headlines